2Kittleson M,Hurwitz S,Shah MR,et al.Development of circulatory-renal limitations to angiotensin-converting enzyme inhibitors identifies patients with severe heart failure and early mortality.J Am Coll Cardiol,2003,41:2029-2035. 被引量:1
3De Bruyne LK.Mechanisms and management of diuretic resistance in congestive heart failure.Postgrad Med J,2003,79:268-271. 被引量:1
4Hall D.Controversies in heart failure.Are beneficial effects of angiotensin-converting enzyme inhibitors attenuated by aspirin in patients with heart failure? Cardiol Clin,2001,19:597-603. 被引量:1
6Jaski BE,Ha J, Denys BG,et al. Peripherally inserted veno-venous ultrafdtration for rapid treatment of volume overloaded patients.J Card Fail,2003,9:227-231. 被引量:1
7Costanzo MR, Saltzberg M, O' Sullivan J, et al. Early ultrafiltration in patients with decompensated heart failure and diuretic resistance.J Am Coll Cardiol,2005,46:2047-2051. 被引量:1
8Givertz MM,Massie BM,Fields TK,et al. The effects of KW-3902,an adenosine A1-receptor antagonist,on diuresis and renal function in patients with acute decompensated heart failure and renal impairment or diuretic resistance.J Am Coll Cardiol,2007,50:1551-1560. 被引量:1
9Cotter G,Dittrich HC,Weatherley BD,et al. The PROTECT pilot study:a randomized,placebo-controlled,dose-finding study of the adenosine Al receptor antagonist rolofylline in patients with acute heart failure and renal impairment.J Card Fail,2008,14: 631-640. 被引量:1
10Paterna S,Di Pasquale P,Parrinello G,et al.Effects of high-dose furosemide and small-volume hypertonic saline solution infusion in comparison with a high dose of furosemide as a bolus, in refractory congestive heart failure.Eur J Heart Fail,2000,2:305-313. 被引量:1